Eulerpool Terminal
The edge that pays for itself.
Current Calidi Biotherapeutics forecasts and price targets in August 2026
Ø Analyst Price Targets
10.20 USD
+562.34 %
Median
10.20 USD
+562.34 %
Max
10.50 USD
Min
10.10 USD
Last Price
1.54 USD
Buy
6
Hold
1
Sell
0
The average target price for Calidi Biotherapeutics is 10.20 USD. (+562.34 % above the current price)
The median price target of Calidi Biotherapeutics is 10.20 USD.
Stock analysts from many renowned investment banks are closely examining the Calidi Biotherapeutics stock. They conclude their professional Calidi Biotherapeutics stock analyses with a clear recommendation for the Calidi Biotherapeutics stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-03-01 | 6 | 1 | 0 | — |
| 2026-02-01 | 6 | 1 | 0 | — |
| 2026-01-01 | 6 | 1 | 0 | — |
| 2025-12-01 | 6 | 1 | 0 | — |
| 2025-11-01 | 6 | 1 | 0 | — |
| 2025-10-01 | 6 | 1 | 0 | — |
Calidi Biotherapeutics Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Calidi Biotherapeutics in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2029e | 15.00 M USD | — | — |